Article
Clinical Significance of TERT Promoter Mutations in Neuroblastoma.
JCO precision oncology - 1 Jul 2025
Persaud Natasha, Gundem Gunes, Kushner Brian H, Ladanyi Marc, Shukla Neerav, Modak Shakeel
Abstract excerpt
PURPOSE: Telomere maintenance mechanisms including MYCN amplification (MYCN-A) (via upregulated telomerase reverse transcriptase [TERT] expression), TERT rearrangements (TERT-RA), and ATRX mutations confer neoplastic immortality in neuroblastoma (NB) cells. Clinical characterization of patients with NB harboring activating somatic TERT promoter point mutations (TERT-PM) in NB may improve stratification. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
